nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—Alzheimer's disease	0.682	1	CbGaD
Dabigatran etexilate—F2—blood vessel—Alzheimer's disease	0.00284	0.153	CbGeAlD
Dabigatran etexilate—CES2—telencephalon—Alzheimer's disease	0.00154	0.0829	CbGeAlD
Dabigatran etexilate—NQO2—telencephalon—Alzheimer's disease	0.00137	0.074	CbGeAlD
Dabigatran etexilate—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000915	0.00454	CcSEcCtD
Dabigatran etexilate—CES2—nervous system—Alzheimer's disease	0.000908	0.0489	CbGeAlD
Dabigatran etexilate—Cardiac failure—Donepezil—Alzheimer's disease	0.000904	0.00449	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Memantine—Alzheimer's disease	0.000884	0.00439	CcSEcCtD
Dabigatran etexilate—Pneumonia—Galantamine—Alzheimer's disease	0.000883	0.00438	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.000883	0.00438	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Donepezil—Alzheimer's disease	0.000883	0.00438	CcSEcCtD
Dabigatran etexilate—CES2—central nervous system—Alzheimer's disease	0.000874	0.0471	CbGeAlD
Dabigatran etexilate—CES2—cerebellum—Alzheimer's disease	0.000854	0.046	CbGeAlD
Dabigatran etexilate—Urinary tract infection—Galantamine—Alzheimer's disease	0.000853	0.00424	CcSEcCtD
Dabigatran etexilate—Haematuria—Galantamine—Alzheimer's disease	0.000837	0.00416	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00083	0.00412	CcSEcCtD
Dabigatran etexilate—Epistaxis—Galantamine—Alzheimer's disease	0.000828	0.00411	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Memantine—Alzheimer's disease	0.000821	0.00408	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Donepezil—Alzheimer's disease	0.000815	0.00405	CcSEcCtD
Dabigatran etexilate—F2—nervous system—Alzheimer's disease	0.000814	0.0439	CbGeAlD
Dabigatran etexilate—NQO2—nervous system—Alzheimer's disease	0.000811	0.0437	CbGeAlD
Dabigatran etexilate—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000806	0.004	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Rivastigmine—Alzheimer's disease	0.000803	0.00399	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Memantine—Alzheimer's disease	0.000801	0.00398	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Memantine—Alzheimer's disease	0.000801	0.00398	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.000801	0.00398	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000795	0.00395	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Galantamine—Alzheimer's disease	0.000792	0.00393	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000789	0.00392	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Galantamine—Alzheimer's disease	0.000788	0.00391	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Rivastigmine—Alzheimer's disease	0.000784	0.00389	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.000784	0.00389	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000784	0.00389	CcSEcCtD
Dabigatran etexilate—F2—central nervous system—Alzheimer's disease	0.000784	0.0422	CbGeAlD
Dabigatran etexilate—Gastritis—Donepezil—Alzheimer's disease	0.000781	0.00388	CcSEcCtD
Dabigatran etexilate—NQO2—central nervous system—Alzheimer's disease	0.000781	0.0421	CbGeAlD
Dabigatran etexilate—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000779	0.00387	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000778	0.00386	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Galantamine—Alzheimer's disease	0.000776	0.00385	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000774	0.00385	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Galantamine—Alzheimer's disease	0.000772	0.00384	CcSEcCtD
Dabigatran etexilate—NQO2—cerebellum—Alzheimer's disease	0.000763	0.0411	CbGeAlD
Dabigatran etexilate—Influenza—Donepezil—Alzheimer's disease	0.000763	0.00379	CcSEcCtD
Dabigatran etexilate—Dysphagia—Donepezil—Alzheimer's disease	0.000763	0.00379	CcSEcCtD
Dabigatran etexilate—CES1—nervous system—Alzheimer's disease	0.000748	0.0403	CbGeAlD
Dabigatran etexilate—Angina pectoris—Donepezil—Alzheimer's disease	0.000743	0.00369	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Memantine—Alzheimer's disease	0.00074	0.00367	CcSEcCtD
Dabigatran etexilate—Bronchitis—Donepezil—Alzheimer's disease	0.000734	0.00364	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000731	0.00363	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Galantamine—Alzheimer's disease	0.000731	0.00363	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000724	0.00359	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000722	0.00358	CcSEcCtD
Dabigatran etexilate—CES1—central nervous system—Alzheimer's disease	0.00072	0.0388	CbGeAlD
Dabigatran etexilate—Nasopharyngitis—Memantine—Alzheimer's disease	0.000717	0.00356	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000716	0.00356	CcSEcCtD
Dabigatran etexilate—Angiopathy—Galantamine—Alzheimer's disease	0.000715	0.00355	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Galantamine—Alzheimer's disease	0.000712	0.00353	CcSEcCtD
Dabigatran etexilate—Gastritis—Memantine—Alzheimer's disease	0.000709	0.00352	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000707	0.00351	CcSEcCtD
Dabigatran etexilate—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000701	0.00348	CcSEcCtD
Dabigatran etexilate—Gastritis—Rivastigmine—Alzheimer's disease	0.000694	0.00345	CcSEcCtD
Dabigatran etexilate—CES2—brain—Alzheimer's disease	0.000694	0.0374	CbGeAlD
Dabigatran etexilate—Influenza—Memantine—Alzheimer's disease	0.000693	0.00344	CcSEcCtD
Dabigatran etexilate—Dysphagia—Memantine—Alzheimer's disease	0.000693	0.00344	CcSEcCtD
Dabigatran etexilate—Malnutrition—Galantamine—Alzheimer's disease	0.000686	0.00341	CcSEcCtD
Dabigatran etexilate—Pneumonia—Donepezil—Alzheimer's disease	0.000684	0.0034	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Memantine—Alzheimer's disease	0.000681	0.00338	CcSEcCtD
Dabigatran etexilate—Infestation—Donepezil—Alzheimer's disease	0.00068	0.00338	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Donepezil—Alzheimer's disease	0.00068	0.00338	CcSEcCtD
Dabigatran etexilate—Dysphagia—Rivastigmine—Alzheimer's disease	0.000678	0.00337	CcSEcCtD
Dabigatran etexilate—Flatulence—Galantamine—Alzheimer's disease	0.000676	0.00336	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Memantine—Alzheimer's disease	0.000675	0.00335	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000671	0.00333	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Donepezil—Alzheimer's disease	0.000667	0.00331	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000667	0.00331	CcSEcCtD
Dabigatran etexilate—Bronchitis—Memantine—Alzheimer's disease	0.000666	0.00331	CcSEcCtD
Dabigatran etexilate—Back pain—Galantamine—Alzheimer's disease	0.000663	0.00329	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Donepezil—Alzheimer's disease	0.000661	0.00328	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00066	0.00328	CcSEcCtD
Dabigatran etexilate—Bronchitis—Rivastigmine—Alzheimer's disease	0.000652	0.00324	CcSEcCtD
Dabigatran etexilate—Haematuria—Donepezil—Alzheimer's disease	0.000649	0.00322	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000644	0.0032	CcSEcCtD
Dabigatran etexilate—Epistaxis—Donepezil—Alzheimer's disease	0.000642	0.00319	CcSEcCtD
Dabigatran etexilate—Anaemia—Galantamine—Alzheimer's disease	0.000634	0.00315	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00063	0.00313	CcSEcCtD
Dabigatran etexilate—F2—brain—Alzheimer's disease	0.000622	0.0335	CbGeAlD
Dabigatran etexilate—Pneumonia—Memantine—Alzheimer's disease	0.000621	0.00309	CcSEcCtD
Dabigatran etexilate—NQO2—brain—Alzheimer's disease	0.00062	0.0334	CbGeAlD
Dabigatran etexilate—Infestation NOS—Memantine—Alzheimer's disease	0.000618	0.00307	CcSEcCtD
Dabigatran etexilate—Infestation—Memantine—Alzheimer's disease	0.000618	0.00307	CcSEcCtD
Dabigatran etexilate—Syncope—Galantamine—Alzheimer's disease	0.000615	0.00305	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Donepezil—Alzheimer's disease	0.000614	0.00305	CcSEcCtD
Dabigatran etexilate—ABCB1—blood vessel—Alzheimer's disease	0.000611	0.0329	CbGeAlD
Dabigatran etexilate—Haemorrhage—Donepezil—Alzheimer's disease	0.000611	0.00303	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000609	0.00302	CcSEcCtD
Dabigatran etexilate—Pneumonia—Rivastigmine—Alzheimer's disease	0.000608	0.00302	CcSEcCtD
Dabigatran etexilate—Palpitations—Galantamine—Alzheimer's disease	0.000606	0.00301	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Memantine—Alzheimer's disease	0.000605	0.00301	CcSEcCtD
Dabigatran etexilate—Infestation—Rivastigmine—Alzheimer's disease	0.000604	0.003	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000604	0.003	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000603	0.00299	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Galantamine—Alzheimer's disease	0.000603	0.00299	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Donepezil—Alzheimer's disease	0.000602	0.00299	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Memantine—Alzheimer's disease	0.0006	0.00298	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Donepezil—Alzheimer's disease	0.000599	0.00297	CcSEcCtD
Dabigatran etexilate—Cough—Galantamine—Alzheimer's disease	0.000599	0.00297	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000596	0.00296	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000592	0.00294	CcSEcCtD
Dabigatran etexilate—Hypertension—Galantamine—Alzheimer's disease	0.000592	0.00294	CcSEcCtD
Dabigatran etexilate—Haematuria—Memantine—Alzheimer's disease	0.000589	0.00292	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000587	0.00292	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000584	0.0029	CcSEcCtD
Dabigatran etexilate—Chest pain—Galantamine—Alzheimer's disease	0.000584	0.0029	CcSEcCtD
Dabigatran etexilate—Arthralgia—Galantamine—Alzheimer's disease	0.000584	0.0029	CcSEcCtD
Dabigatran etexilate—Epistaxis—Memantine—Alzheimer's disease	0.000583	0.00289	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00058	0.00288	CcSEcCtD
Dabigatran etexilate—Sinusitis—Memantine—Alzheimer's disease	0.000579	0.00288	CcSEcCtD
Dabigatran etexilate—Haematuria—Rivastigmine—Alzheimer's disease	0.000576	0.00286	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000571	0.00284	CcSEcCtD
Dabigatran etexilate—CES1—brain—Alzheimer's disease	0.000571	0.0308	CbGeAlD
Dabigatran etexilate—Epistaxis—Rivastigmine—Alzheimer's disease	0.00057	0.00283	CcSEcCtD
Dabigatran etexilate—Sinusitis—Rivastigmine—Alzheimer's disease	0.000567	0.00282	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Memantine—Alzheimer's disease	0.000557	0.00277	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Memantine—Alzheimer's disease	0.000554	0.00275	CcSEcCtD
Dabigatran etexilate—Shock—Galantamine—Alzheimer's disease	0.000551	0.00274	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000549	0.00273	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000548	0.00272	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Memantine—Alzheimer's disease	0.000548	0.00272	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Memantine—Alzheimer's disease	0.000546	0.00271	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000545	0.00271	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Memantine—Alzheimer's disease	0.000545	0.00271	CcSEcCtD
Dabigatran etexilate—Skin disorder—Galantamine—Alzheimer's disease	0.000544	0.0027	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Memantine—Alzheimer's disease	0.000544	0.0027	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000542	0.00269	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000536	0.00266	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000534	0.00265	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000533	0.00265	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000532	0.00264	CcSEcCtD
Dabigatran etexilate—Malnutrition—Donepezil—Alzheimer's disease	0.000532	0.00264	CcSEcCtD
Dabigatran etexilate—Flatulence—Donepezil—Alzheimer's disease	0.000524	0.0026	CcSEcCtD
Dabigatran etexilate—Hypotension—Galantamine—Alzheimer's disease	0.000523	0.0026	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Memantine—Alzheimer's disease	0.000515	0.00256	CcSEcCtD
Dabigatran etexilate—Back pain—Donepezil—Alzheimer's disease	0.000514	0.00255	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00051	0.00253	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000503	0.0025	CcSEcCtD
Dabigatran etexilate—Angiopathy—Memantine—Alzheimer's disease	0.000503	0.0025	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Memantine—Alzheimer's disease	0.000501	0.00249	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Memantine—Alzheimer's disease	0.0005	0.00248	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Galantamine—Alzheimer's disease	0.000493	0.00245	CcSEcCtD
Dabigatran etexilate—Angiopathy—Rivastigmine—Alzheimer's disease	0.000492	0.00244	CcSEcCtD
Dabigatran etexilate—Anaemia—Donepezil—Alzheimer's disease	0.000491	0.00244	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000489	0.00243	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000483	0.0024	CcSEcCtD
Dabigatran etexilate—Malnutrition—Memantine—Alzheimer's disease	0.000483	0.0024	CcSEcCtD
Dabigatran etexilate—Fatigue—Galantamine—Alzheimer's disease	0.000483	0.0024	CcSEcCtD
Dabigatran etexilate—Constipation—Galantamine—Alzheimer's disease	0.000479	0.00238	CcSEcCtD
Dabigatran etexilate—Syncope—Donepezil—Alzheimer's disease	0.000477	0.00237	CcSEcCtD
Dabigatran etexilate—Flatulence—Memantine—Alzheimer's disease	0.000476	0.00236	CcSEcCtD
Dabigatran etexilate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000472	0.00234	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000467	0.00232	CcSEcCtD
Dabigatran etexilate—Back pain—Memantine—Alzheimer's disease	0.000467	0.00232	CcSEcCtD
Dabigatran etexilate—Flatulence—Rivastigmine—Alzheimer's disease	0.000465	0.00231	CcSEcCtD
Dabigatran etexilate—Cough—Donepezil—Alzheimer's disease	0.000464	0.0023	CcSEcCtD
Dabigatran etexilate—Hypertension—Donepezil—Alzheimer's disease	0.000459	0.00228	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000458	0.00227	CcSEcCtD
Dabigatran etexilate—Back pain—Rivastigmine—Alzheimer's disease	0.000457	0.00227	CcSEcCtD
Dabigatran etexilate—Chest pain—Donepezil—Alzheimer's disease	0.000453	0.00225	CcSEcCtD
Dabigatran etexilate—Arthralgia—Donepezil—Alzheimer's disease	0.000453	0.00225	CcSEcCtD
Dabigatran etexilate—Anaemia—Memantine—Alzheimer's disease	0.000446	0.00222	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Galantamine—Alzheimer's disease	0.000443	0.0022	CcSEcCtD
Dabigatran etexilate—Anaemia—Rivastigmine—Alzheimer's disease	0.000436	0.00217	CcSEcCtD
Dabigatran etexilate—Syncope—Memantine—Alzheimer's disease	0.000433	0.00215	CcSEcCtD
Dabigatran etexilate—Infection—Donepezil—Alzheimer's disease	0.000431	0.00214	CcSEcCtD
Dabigatran etexilate—Shock—Donepezil—Alzheimer's disease	0.000427	0.00212	CcSEcCtD
Dabigatran etexilate—Palpitations—Memantine—Alzheimer's disease	0.000427	0.00212	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000425	0.00211	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000425	0.00211	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Memantine—Alzheimer's disease	0.000424	0.00211	CcSEcCtD
Dabigatran etexilate—Syncope—Rivastigmine—Alzheimer's disease	0.000423	0.0021	CcSEcCtD
Dabigatran etexilate—Cough—Memantine—Alzheimer's disease	0.000421	0.00209	CcSEcCtD
Dabigatran etexilate—Palpitations—Rivastigmine—Alzheimer's disease	0.000417	0.00207	CcSEcCtD
Dabigatran etexilate—Hypertension—Memantine—Alzheimer's disease	0.000417	0.00207	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000415	0.00206	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Galantamine—Alzheimer's disease	0.000412	0.00205	CcSEcCtD
Dabigatran etexilate—Cough—Rivastigmine—Alzheimer's disease	0.000412	0.00205	CcSEcCtD
Dabigatran etexilate—Arthralgia—Memantine—Alzheimer's disease	0.000411	0.00204	CcSEcCtD
Dabigatran etexilate—Chest pain—Memantine—Alzheimer's disease	0.000411	0.00204	CcSEcCtD
Dabigatran etexilate—Hypertension—Rivastigmine—Alzheimer's disease	0.000408	0.00202	CcSEcCtD
Dabigatran etexilate—Hypotension—Donepezil—Alzheimer's disease	0.000405	0.00201	CcSEcCtD
Dabigatran etexilate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000402	0.002	CcSEcCtD
Dabigatran etexilate—Chest pain—Rivastigmine—Alzheimer's disease	0.000402	0.002	CcSEcCtD
Dabigatran etexilate—Asthenia—Galantamine—Alzheimer's disease	0.000402	0.00199	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000399	0.00198	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000395	0.00196	CcSEcCtD
Dabigatran etexilate—Infection—Memantine—Alzheimer's disease	0.000391	0.00194	CcSEcCtD
Dabigatran etexilate—Shock—Memantine—Alzheimer's disease	0.000388	0.00192	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Donepezil—Alzheimer's disease	0.000387	0.00192	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Memantine—Alzheimer's disease	0.000386	0.00192	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Memantine—Alzheimer's disease	0.000386	0.00192	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Galantamine—Alzheimer's disease	0.000383	0.0019	CcSEcCtD
Dabigatran etexilate—Infection—Rivastigmine—Alzheimer's disease	0.000383	0.0019	CcSEcCtD
Dabigatran etexilate—Skin disorder—Memantine—Alzheimer's disease	0.000383	0.0019	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Donepezil—Alzheimer's disease	0.000382	0.0019	CcSEcCtD
Dabigatran etexilate—Shock—Rivastigmine—Alzheimer's disease	0.000379	0.00188	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000378	0.00188	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000377	0.00187	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000375	0.00186	CcSEcCtD
Dabigatran etexilate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000374	0.00186	CcSEcCtD
Dabigatran etexilate—Fatigue—Donepezil—Alzheimer's disease	0.000374	0.00186	CcSEcCtD
Dabigatran etexilate—Constipation—Donepezil—Alzheimer's disease	0.000371	0.00184	CcSEcCtD
Dabigatran etexilate—Dizziness—Galantamine—Alzheimer's disease	0.00037	0.00184	CcSEcCtD
Dabigatran etexilate—Hypotension—Memantine—Alzheimer's disease	0.000368	0.00183	CcSEcCtD
Dabigatran etexilate—ABCB1—embryo—Alzheimer's disease	0.000365	0.0197	CbGeAlD
Dabigatran etexilate—Hypotension—Rivastigmine—Alzheimer's disease	0.00036	0.00179	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000359	0.00178	CcSEcCtD
Dabigatran etexilate—Vomiting—Galantamine—Alzheimer's disease	0.000356	0.00177	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000355	0.00176	CcSEcCtD
Dabigatran etexilate—Rash—Galantamine—Alzheimer's disease	0.000353	0.00175	CcSEcCtD
Dabigatran etexilate—Dermatitis—Galantamine—Alzheimer's disease	0.000353	0.00175	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Memantine—Alzheimer's disease	0.000351	0.00174	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000351	0.00174	CcSEcCtD
Dabigatran etexilate—Headache—Galantamine—Alzheimer's disease	0.000351	0.00174	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Memantine—Alzheimer's disease	0.000347	0.00172	CcSEcCtD
Dabigatran etexilate—Urticaria—Donepezil—Alzheimer's disease	0.000345	0.00171	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000344	0.00171	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Donepezil—Alzheimer's disease	0.000343	0.0017	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00034	0.00169	CcSEcCtD
Dabigatran etexilate—Fatigue—Memantine—Alzheimer's disease	0.00034	0.00169	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000339	0.00168	CcSEcCtD
Dabigatran etexilate—Constipation—Memantine—Alzheimer's disease	0.000337	0.00167	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000333	0.00165	CcSEcCtD
Dabigatran etexilate—Nausea—Galantamine—Alzheimer's disease	0.000333	0.00165	CcSEcCtD
Dabigatran etexilate—Fatigue—Rivastigmine—Alzheimer's disease	0.000332	0.00165	CcSEcCtD
Dabigatran etexilate—Constipation—Rivastigmine—Alzheimer's disease	0.00033	0.00164	CcSEcCtD
Dabigatran etexilate—ABCB1—forebrain—Alzheimer's disease	0.000323	0.0174	CbGeAlD
Dabigatran etexilate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000322	0.0016	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Donepezil—Alzheimer's disease	0.00032	0.00159	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000315	0.00156	CcSEcCtD
Dabigatran etexilate—Urticaria—Memantine—Alzheimer's disease	0.000313	0.00155	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Memantine—Alzheimer's disease	0.000311	0.00155	CcSEcCtD
Dabigatran etexilate—Asthenia—Donepezil—Alzheimer's disease	0.000311	0.00155	CcSEcCtD
Dabigatran etexilate—Pruritus—Donepezil—Alzheimer's disease	0.000307	0.00152	CcSEcCtD
Dabigatran etexilate—Urticaria—Rivastigmine—Alzheimer's disease	0.000306	0.00152	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000305	0.00151	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Donepezil—Alzheimer's disease	0.000297	0.00147	CcSEcCtD
Dabigatran etexilate—ABCB1—telencephalon—Alzheimer's disease	0.000297	0.016	CbGeAlD
Dabigatran etexilate—Hypersensitivity—Memantine—Alzheimer's disease	0.00029	0.00144	CcSEcCtD
Dabigatran etexilate—Dizziness—Donepezil—Alzheimer's disease	0.000287	0.00142	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000284	0.00141	CcSEcCtD
Dabigatran etexilate—Asthenia—Memantine—Alzheimer's disease	0.000283	0.0014	CcSEcCtD
Dabigatran etexilate—Pruritus—Memantine—Alzheimer's disease	0.000279	0.00138	CcSEcCtD
Dabigatran etexilate—Asthenia—Rivastigmine—Alzheimer's disease	0.000276	0.00137	CcSEcCtD
Dabigatran etexilate—Vomiting—Donepezil—Alzheimer's disease	0.000276	0.00137	CcSEcCtD
Dabigatran etexilate—Rash—Donepezil—Alzheimer's disease	0.000274	0.00136	CcSEcCtD
Dabigatran etexilate—Dermatitis—Donepezil—Alzheimer's disease	0.000273	0.00136	CcSEcCtD
Dabigatran etexilate—Pruritus—Rivastigmine—Alzheimer's disease	0.000273	0.00135	CcSEcCtD
Dabigatran etexilate—Headache—Donepezil—Alzheimer's disease	0.000272	0.00135	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Memantine—Alzheimer's disease	0.00027	0.00134	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000264	0.00131	CcSEcCtD
Dabigatran etexilate—Dizziness—Memantine—Alzheimer's disease	0.00026	0.00129	CcSEcCtD
Dabigatran etexilate—Nausea—Donepezil—Alzheimer's disease	0.000258	0.00128	CcSEcCtD
Dabigatran etexilate—Dizziness—Rivastigmine—Alzheimer's disease	0.000255	0.00127	CcSEcCtD
Dabigatran etexilate—Vomiting—Memantine—Alzheimer's disease	0.00025	0.00124	CcSEcCtD
Dabigatran etexilate—Rash—Memantine—Alzheimer's disease	0.000248	0.00123	CcSEcCtD
Dabigatran etexilate—Dermatitis—Memantine—Alzheimer's disease	0.000248	0.00123	CcSEcCtD
Dabigatran etexilate—Headache—Memantine—Alzheimer's disease	0.000247	0.00123	CcSEcCtD
Dabigatran etexilate—Vomiting—Rivastigmine—Alzheimer's disease	0.000245	0.00122	CcSEcCtD
Dabigatran etexilate—Rash—Rivastigmine—Alzheimer's disease	0.000243	0.00121	CcSEcCtD
Dabigatran etexilate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000243	0.00121	CcSEcCtD
Dabigatran etexilate—Headache—Rivastigmine—Alzheimer's disease	0.000241	0.0012	CcSEcCtD
Dabigatran etexilate—Nausea—Memantine—Alzheimer's disease	0.000234	0.00116	CcSEcCtD
Dabigatran etexilate—Nausea—Rivastigmine—Alzheimer's disease	0.000229	0.00114	CcSEcCtD
Dabigatran etexilate—ABCB1—nervous system—Alzheimer's disease	0.000175	0.00944	CbGeAlD
Dabigatran etexilate—ABCB1—central nervous system—Alzheimer's disease	0.000169	0.00909	CbGeAlD
Dabigatran etexilate—ABCB1—cerebellum—Alzheimer's disease	0.000165	0.00888	CbGeAlD
Dabigatran etexilate—ABCB1—brain—Alzheimer's disease	0.000134	0.00721	CbGeAlD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.88e-05	0.000597	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—BCHE—Alzheimer's disease	5.84e-05	0.000593	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PLCB1—Alzheimer's disease	5.82e-05	0.000591	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.81e-05	0.00059	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF2—Alzheimer's disease	5.75e-05	0.000584	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	5.72e-05	0.000581	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—ACE—Alzheimer's disease	5.66e-05	0.000574	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HSD17B10—Alzheimer's disease	5.64e-05	0.000572	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCA1—Alzheimer's disease	5.64e-05	0.000572	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	5.63e-05	0.000571	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—Alzheimer's disease	5.58e-05	0.000566	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	5.52e-05	0.000561	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—NPY—Alzheimer's disease	5.52e-05	0.00056	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.51e-05	0.00056	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.51e-05	0.00056	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCR5—Alzheimer's disease	5.49e-05	0.000558	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IAPP—Alzheimer's disease	5.48e-05	0.000557	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PYY—Alzheimer's disease	5.44e-05	0.000552	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP46A1—Alzheimer's disease	5.43e-05	0.000551	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR2A—Alzheimer's disease	5.37e-05	0.000546	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CRH—Alzheimer's disease	5.32e-05	0.000541	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ND1—Alzheimer's disease	5.24e-05	0.000532	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PRKCG—Alzheimer's disease	5.18e-05	0.000526	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.12e-05	0.00052	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—NPS—Alzheimer's disease	5.05e-05	0.000513	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—NPY—Alzheimer's disease	5.01e-05	0.000509	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IAPP—Alzheimer's disease	4.98e-05	0.000506	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARGC1A—Alzheimer's disease	4.86e-05	0.000493	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—HMOX1—Alzheimer's disease	4.84e-05	0.000491	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CRH—Alzheimer's disease	4.83e-05	0.000491	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GAB2—Alzheimer's disease	4.81e-05	0.000489	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—SST—Alzheimer's disease	4.81e-05	0.000489	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDK5—Alzheimer's disease	4.71e-05	0.000479	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	4.69e-05	0.000477	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—APP—Alzheimer's disease	4.69e-05	0.000476	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.68e-05	0.000476	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	4.68e-05	0.000475	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—NPS—Alzheimer's disease	4.58e-05	0.000465	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.56e-05	0.000463	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR6—Alzheimer's disease	4.54e-05	0.000461	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—Alzheimer's disease	4.53e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLAU—Alzheimer's disease	4.53e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF2—Alzheimer's disease	4.52e-05	0.000459	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CALM1—Alzheimer's disease	4.48e-05	0.000455	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.43e-05	0.00045	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CAV1—Alzheimer's disease	4.42e-05	0.000449	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—LPL—Alzheimer's disease	4.42e-05	0.000449	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	4.37e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—SST—Alzheimer's disease	4.37e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GAB2—Alzheimer's disease	4.37e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	4.36e-05	0.000443	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	4.31e-05	0.000438	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	4.29e-05	0.000436	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	4.28e-05	0.000434	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—APP—Alzheimer's disease	4.26e-05	0.000433	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—Alzheimer's disease	4.2e-05	0.000426	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—Alzheimer's disease	4.16e-05	0.000423	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TPI1—Alzheimer's disease	4.16e-05	0.000422	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CHAT—Alzheimer's disease	4.16e-05	0.000422	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PSENEN—Alzheimer's disease	4.12e-05	0.000418	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APH1A—Alzheimer's disease	4.06e-05	0.000413	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.04e-05	0.00041	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PLCB1—Alzheimer's disease	4.02e-05	0.000408	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	4.01e-05	0.000407	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MAOB—Alzheimer's disease	3.98e-05	0.000405	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MTHFR—Alzheimer's disease	3.98e-05	0.000404	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NCSTN—Alzheimer's disease	3.96e-05	0.000402	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LRP1—Alzheimer's disease	3.86e-05	0.000392	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GAPDH—Alzheimer's disease	3.84e-05	0.00039	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GFAP—Alzheimer's disease	3.77e-05	0.000383	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAL—Alzheimer's disease	3.77e-05	0.000383	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DHCR24—Alzheimer's disease	3.73e-05	0.000379	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CALM1—Alzheimer's disease	3.72e-05	0.000378	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOE—Alzheimer's disease	3.71e-05	0.000377	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—A2M—Alzheimer's disease	3.7e-05	0.000376	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	3.7e-05	0.000376	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IGF1—Alzheimer's disease	3.69e-05	0.000375	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.68e-05	0.000373	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CAV1—Alzheimer's disease	3.67e-05	0.000373	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LEP—Alzheimer's disease	3.51e-05	0.000357	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	3.4e-05	0.000345	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TPI1—Alzheimer's disease	3.38e-05	0.000343	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CHAT—Alzheimer's disease	3.38e-05	0.000343	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS3—Alzheimer's disease	3.35e-05	0.00034	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—A2M—Alzheimer's disease	3.32e-05	0.000337	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	3.31e-05	0.000336	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.27e-05	0.000332	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MAOB—Alzheimer's disease	3.24e-05	0.000329	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.23e-05	0.000328	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—Alzheimer's disease	3.23e-05	0.000328	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ACHE—Alzheimer's disease	3.22e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PSEN2—Alzheimer's disease	3.22e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INPP5D—Alzheimer's disease	3.19e-05	0.000323	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	3.17e-05	0.000322	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CA4—Alzheimer's disease	3.17e-05	0.000322	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—INS—Alzheimer's disease	3.17e-05	0.000322	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GAPDH—Alzheimer's disease	3.12e-05	0.000317	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR5—Alzheimer's disease	3.1e-05	0.000315	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.08e-05	0.000313	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.05e-05	0.00031	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.04e-05	0.000308	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS1—Alzheimer's disease	3.02e-05	0.000307	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ENO1—Alzheimer's disease	3.02e-05	0.000307	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—A2M—Alzheimer's disease	3.01e-05	0.000306	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—INS—Alzheimer's disease	3e-05	0.000305	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	2.98e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	2.98e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.97e-05	0.000302	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2D6—Alzheimer's disease	2.96e-05	0.000301	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPY—Alzheimer's disease	2.96e-05	0.000301	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—Alzheimer's disease	2.95e-05	0.0003	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.95e-05	0.000299	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IAPP—Alzheimer's disease	2.94e-05	0.000299	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	2.91e-05	0.000295	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—IGF1—Alzheimer's disease	2.9e-05	0.000295	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CRH—Alzheimer's disease	2.86e-05	0.00029	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	2.83e-05	0.000287	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR5—Alzheimer's disease	2.82e-05	0.000286	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—BCHE—Alzheimer's disease	2.81e-05	0.000285	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	2.8e-05	0.000284	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NOS3—Alzheimer's disease	2.78e-05	0.000282	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2A—Alzheimer's disease	2.76e-05	0.00028	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	2.73e-05	0.000277	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPS—Alzheimer's disease	2.71e-05	0.000275	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLD3—Alzheimer's disease	2.7e-05	0.000274	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PPP3CA—Alzheimer's disease	2.69e-05	0.000274	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.68e-05	0.000273	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTK2B—Alzheimer's disease	2.65e-05	0.00027	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PLCB1—Alzheimer's disease	2.65e-05	0.000269	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ACHE—Alzheimer's disease	2.62e-05	0.000266	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INPP5D—Alzheimer's disease	2.59e-05	0.000263	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	2.59e-05	0.000263	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK2—Alzheimer's disease	2.58e-05	0.000262	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAB2—Alzheimer's disease	2.58e-05	0.000262	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SST—Alzheimer's disease	2.58e-05	0.000262	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CALM1—Alzheimer's disease	2.57e-05	0.000261	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCA1—Alzheimer's disease	2.57e-05	0.000261	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GSK3A—Alzheimer's disease	2.56e-05	0.00026	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—Alzheimer's disease	2.54e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APP—Alzheimer's disease	2.52e-05	0.000256	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.51e-05	0.000255	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	2.49e-05	0.000253	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ENO1—Alzheimer's disease	2.45e-05	0.000249	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS1—Alzheimer's disease	2.45e-05	0.000249	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.44e-05	0.000248	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—Alzheimer's disease	2.41e-05	0.000245	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2D6—Alzheimer's disease	2.41e-05	0.000244	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ND1—Alzheimer's disease	2.4e-05	0.000244	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLCB1—Alzheimer's disease	2.37e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.32e-05	0.000236	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—BCHE—Alzheimer's disease	2.28e-05	0.000232	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NGFR—Alzheimer's disease	2.22e-05	0.000225	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARGC1A—Alzheimer's disease	2.21e-05	0.000225	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—Alzheimer's disease	2.21e-05	0.000225	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—Alzheimer's disease	2.2e-05	0.000224	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CREB1—Alzheimer's disease	2.2e-05	0.000224	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADAM10—Alzheimer's disease	2.16e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—Alzheimer's disease	2.15e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.15e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLCB1—Alzheimer's disease	2.15e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.11e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCA1—Alzheimer's disease	2.09e-05	0.000212	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—S100B—Alzheimer's disease	2.05e-05	0.000208	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LPL—Alzheimer's disease	2.01e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.98e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF2—Alzheimer's disease	1.95e-05	0.000198	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1R—Alzheimer's disease	1.88e-05	0.000191	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.83e-05	0.000186	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—Alzheimer's disease	1.82e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—Alzheimer's disease	1.81e-05	0.000184	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LPL—Alzheimer's disease	1.81e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARGC1A—Alzheimer's disease	1.8e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MEF2C—Alzheimer's disease	1.79e-05	0.000182	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—Alzheimer's disease	1.79e-05	0.000182	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCG—Alzheimer's disease	1.76e-05	0.000178	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.75e-05	0.000178	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NGF—Alzheimer's disease	1.71e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CALM1—Alzheimer's disease	1.69e-05	0.000172	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—Alzheimer's disease	1.69e-05	0.000172	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.68e-05	0.00017	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAV1—Alzheimer's disease	1.67e-05	0.00017	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR5—Alzheimer's disease	1.66e-05	0.000169	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPL—Alzheimer's disease	1.64e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—Alzheimer's disease	1.63e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.57e-05	0.000159	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.55e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.55e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—Alzheimer's disease	1.54e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CALM1—Alzheimer's disease	1.52e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—Alzheimer's disease	1.51e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—Alzheimer's disease	1.51e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CAV1—Alzheimer's disease	1.5e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.49e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	1.47e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—Alzheimer's disease	1.47e-05	0.000149	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ESR1—Alzheimer's disease	1.45e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—Alzheimer's disease	1.44e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.43e-05	0.000145	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.4e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—A2M—Alzheimer's disease	1.38e-05	0.00014	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.38e-05	0.00014	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CALM1—Alzheimer's disease	1.38e-05	0.00014	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—Alzheimer's disease	1.37e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAV1—Alzheimer's disease	1.36e-05	0.000138	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GSK3B—Alzheimer's disease	1.31e-05	0.000133	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CREB1—Alzheimer's disease	1.3e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—Alzheimer's disease	1.29e-05	0.000131	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—Alzheimer's disease	1.28e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—Alzheimer's disease	1.27e-05	0.000129	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—Alzheimer's disease	1.27e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1—Alzheimer's disease	1.25e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.2e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—Alzheimer's disease	1.2e-05	0.000121	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.19e-05	0.000121	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—Alzheimer's disease	1.17e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.17e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—Alzheimer's disease	1.16e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—Alzheimer's disease	1.13e-05	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.13e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.13e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.05e-05	0.000106	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—Alzheimer's disease	1.03e-05	0.000104	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLCB1—Alzheimer's disease	9.87e-06	0.0001	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—Alzheimer's disease	9.72e-06	9.87e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CASP3—Alzheimer's disease	9.63e-06	9.78e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCA1—Alzheimer's disease	9.57e-06	9.72e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—Alzheimer's disease	9.57e-06	9.72e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	9.4e-06	9.55e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK8—Alzheimer's disease	8.85e-06	8.99e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—Alzheimer's disease	8.83e-06	8.96e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	8.25e-06	8.38e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—Alzheimer's disease	8.21e-06	8.34e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—Alzheimer's disease	8.17e-06	8.3e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPL—Alzheimer's disease	7.51e-06	7.63e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—Alzheimer's disease	7.5e-06	7.62e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—Alzheimer's disease	6.76e-06	6.87e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CALM1—Alzheimer's disease	6.32e-06	6.42e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—Alzheimer's disease	6.3e-06	6.39e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAV1—Alzheimer's disease	6.24e-06	6.33e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—Alzheimer's disease	6.17e-06	6.27e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—Alzheimer's disease	5.82e-06	5.91e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—Alzheimer's disease	5.65e-06	5.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—Alzheimer's disease	5.48e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—Alzheimer's disease	5.38e-06	5.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—Alzheimer's disease	5.21e-06	5.3e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—Alzheimer's disease	4.73e-06	4.8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—Alzheimer's disease	4.72e-06	4.79e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—Alzheimer's disease	4.31e-06	4.38e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.17e-06	2.2e-05	CbGpPWpGaD
